IP Library Granted Patent US 12,280,168
Granted Patent B2
US 12,280,168 · App. 17/437,097 · Granted Apr 22, 2025

Method for sanitization of a chromatography column

Inventors: Johan Avallin (Uppsala, SE); Anna Gronberg (Uppsala, SE); Anders Nilsson (Uppsala, SE); Henrik Ingvarsson (Uppsala, SE); Linda Persson (Uppsala, SE); Magnus Asplund (Uppsala, SE); Reinhard Braaz (Penzberg, DE)
Assignee: Cytiva Sweden AB
A61L2/186B01D15/203B01D15/3809G01N30/50G01N30/56G01N30/6021G01N30/6026A61L2101/36A61L2202/23
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,280,168
App. No.
17/437,097
Granted
Apr 22, 2025
Kind
B2
Abstract

The invention discloses a method for sanitization of a bioprocess chromatography column, comprising the steps of: a) providing a bioprocess chromatography column with a packed bed of separation resin particles and a movable adapter, b) with the adapter in contact with the packed bed, conveying a sanitization fluid through the packed bed to a column outlet; c) raising the adapter to provide a gap between the packed bed and the adapter, d) lowering the adapter to close the gap; and e) conveying an equilibration liquid through the packed bed to a column outlet.

Claims (25)

1. A method for sanitization of a bioprocess chromatography column, comprising the steps of:

a) providing a bioprocess chromatography column with a packed bed of separation resin particles and a movable adapter;

b) with the adapter in contact with the packed bed, conveying a sanitization fluid through the packed bed to a column outlet;

b′) closing and opening a column resin valve;

c) raising the adapter to provide a gap between the packed bed and the adapter;

d) lowering the adapter to close the gap;

d′) conveying the sanitization fluid through the packed bed to the column outlet; and

e) conveying an equilibration liquid through the packed bed to a column outlet.

2. The method of claim 1 , wherein steps c) and d) are repeated at least once.

3. The method of claim 1 , wherein before step b′), said column resin valve has been equilibrated with the sanitization fluid.

4. The method of claim 1 , further comprising filling a flush channel between two adapter seals with the sanitization fluid.

5. The method of claim 1 , wherein said sanitization fluid comprises an oxidizing agent.

6. The method of claim 5 , wherein said oxidizing agent comprises a peracid or hydrogen peroxide.

7. The method of claim 5 , wherein said oxidizing agent comprises or is peracetic acid.

8. The method of claim 5 , wherein the concentration of the oxidizing agent in said sanitization fluid is 5-100 mM.

9. The method of claim 1 , wherein said separation resin comprises a crosslinked polysaccharide.

10. The method of claim 1 , wherein proteinaceous affinity ligands are tethered to said separation resin.

11. The method of claim 10 , wherein said proteinaceous affinity ligands comprise Protein A or a variant of Protein A.

12. The method of claim 1 , wherein said packed bed of separation resin is in contact with said sanitization fluid for 10-50 minutes.

13. The method of claim 1 , wherein, before step b), said column with said packed bed of separation resin is used for separation of a biopharmaceutical.

14. The method of claim 1 , wherein, after step e), said column with said packed bed of separation resin is used for separation of a biopharmaceutical.

15. The method of claim 1 , wherein, before step b), said column with said packed bed of separation resin is used for separation of a first biopharmaceutical and, after step e), said column with said packed bed of separation resin is used for separation of a second biopharmaceutical which is different from said first biopharmaceutical.

16. The method of claim 5 , wherein the concentration of the oxidizing agent in said sanitization fluid is 10-30 mM.

17. The method of claim 9 , wherein said separation resin comprises crosslinked agarose.

18. The method of claim 1 , wherein said packed bed of separation resin is in contact with said sanitization fluid for 20-40 minutes.

Assignments (6)
CHANGE OF NAME Recorded Jan 6, 2022
From: GE HEALTHCARE BIO-SCIENCES AB
To: CYTIVA SWEDEN AB
Reel/Frame 058663/0515 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2021
From: BRAAZ, REINHARD
To: ROCHE DIAGNOSTICS GMBH
Reel/Frame 058205/0128 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2021
From: ROCHE DIAGNOSTICS GMBH
To: F. HOFFMAN-LA ROCHE AG
Reel/Frame 058205/0175 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2021
From: F. HOFFMAN-LA ROCHE AG
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 058205/0229 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2021
From: AVALLIN, JOHAN; GRONBERG, ANNA; NILSSON, ANDERS; INGVARSSON, HENRIK; PERSSON, LINDA; ASPLUND, MAGNUS
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 058205/0336 →
CHANGE OF NAME Recorded Nov 24, 2021
From: GE HEALTHCARE BIO-SCIENCES AB
To: CYTIVA SWEDEN AB
Reel/Frame 058727/0672 →
Priority Claims (1)
GB 1904125 · Mar 26, 2019 · national
Continuity (1)
Related Publication 20220175992A1 · Jun 9, 2022
References Cited (17)
US 5902485A · Davis et al. · 1999 [cited by applicant]
US 20030098280A1 · Davis et al. · 2003 [cited by applicant]
US 20130248430A1 · Gu · 2013 [cited by applicant]
US 20150328563A1 · Lacki et al. · 2015 [cited by applicant]
US 20180036445A1 · Monie et al. · 2018 [cited by applicant]
JP 10503470A · 1998 [cited by applicant]
JP 2016507729A · 2016 [cited by applicant]
JP 2017146239A · 2017 [cited by applicant]
JP 2018044921A · 2018 [cited by applicant]
WO 9526711A1 · 1995 [cited by applicant]
WO 14092636A1 · 2014 [cited by applicant]
WO 2016139128A1 · 2016 [cited by applicant]
WO 2015118609A · 2017 [cited by applicant]
PCT International Search Report and Written Opinion for PCT/EP2020/058023 mailed May 26, 2020 (9 pages). [cited by applicant]
Great Britain Search Report for GB Application No. 11904125.0 mailed Sep. 25, 2019 (5 pages). [cited by applicant]
Japanese Office Action for JP 2021-557165, mailed Jan. 15, 2024 (9 pages). [cited by applicant]
Korean Office Action issued in corresponding KR Application No. 10-2021-7029926, mailed Feb. 7, 2025, 19 pages. [cited by applicant]